Total Payments
$551,939
2024 Payments
$52,550
Companies
12
Transactions
683
Medicare Patients
618
Medicare Billing
$195,373
Payment Breakdown by Category
Other$477,983 (86.6%)
Travel$46,027 (8.3%)
Food & Beverage$14,313 (2.6%)
Consulting$13,298 (2.4%)
Education$318.64 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $411,140 | 207 | 74.5% |
| Honoraria | $66,843 | 30 | 12.1% |
| Travel and Lodging | $46,027 | 121 | 8.3% |
| Food and Beverage | $14,313 | 310 | 2.6% |
| Consulting Fee | $13,298 | 8 | 2.4% |
| Education | $318.64 | 7 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $190,768 | 208 | $0 (2022) |
| ABBVIE INC. | $123,585 | 157 | $0 (2024) |
| Lundbeck LLC | $81,888 | 89 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $67,311 | 86 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $53,632 | 80 | $0 (2023) |
| Allergan, Inc. | $33,927 | 48 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $230.56 | 3 | $0 (2024) |
| Lilly USA, LLC | $199.86 | 7 | $0 (2019) |
| BOSTON SCIENTIFIC CORPORATION | $118.38 | 1 | $0 (2017) |
| GENZYME CORPORATION | $110.94 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52,550 | 66 | ABBVIE INC. ($39,691) |
| 2023 | $76,809 | 104 | ABBVIE INC. ($55,341) |
| 2022 | $35,918 | 38 | Lundbeck LLC ($29,041) |
| 2021 | $133,152 | 153 | Biohaven Pharmaceuticals, Inc. ($67,311) |
| 2020 | $81,101 | 81 | Amgen Inc. ($41,432) |
| 2019 | $116,198 | 143 | Amgen Inc. ($84,055) |
| 2018 | $55,742 | 90 | Amgen Inc. ($46,316) |
| 2017 | $469.13 | 8 | Allergan Inc. ($130.54) |
All Payment Transactions
683 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Honoraria | Cash or cash equivalent | $3,680.00 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | Lundbeck LLC | VYEPTI (Biological) | Travel and Lodging | Cash or cash equivalent | $245.84 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $109.71 | General |
| Category: NEUROLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $920.00 | General |
| Category: NEUROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $47.08 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2024 | Lundbeck LLC | VYEPTI (Biological) | Travel and Lodging | Cash or cash equivalent | $40.00 | General |
| Category: NEUROLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $10.67 | General |
| Category: NEUROLOGY | ||||||
| 07/17/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $70.50 | General |
| Category: NEUROLOGY | ||||||
| 06/24/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 06/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Honoraria | Cash or cash equivalent | $2,760.00 | General |
| Category: NEUROLOGY | ||||||
| 06/18/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $122.27 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 163 | 6,894 | $277,589 | $55,496 |
| 2022 | 4 | 169 | 15,130 | $381,464 | $93,903 |
| 2021 | 5 | 139 | 285 | $123,700 | $24,688 |
| 2020 | 4 | 147 | 273 | $113,874 | $21,286 |
Total Patients
618
Total Services
22,582
Medicare Billing
$195,373
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 30 | 6,645 | $166,325 | $32,169 | 19.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 65 | 172 | $84,236 | $17,414 | 20.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 44 | 53 | $15,866 | $3,500 | 22.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $11,162 | $2,414 | 21.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 47 | 14,867 | $268,421 | $70,145 | 26.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 63 | 198 | $96,426 | $19,929 | 20.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 37 | $10,989 | $2,539 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 28 | $5,628 | $1,290 | 22.9% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 64 | 200 | $97,400 | $18,310 | 18.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 32 | $9,504 | $2,453 | 25.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 17 | $6,800 | $1,974 | 29.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 22 | 23 | $7,383 | $1,302 | 17.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 13 | $2,613 | $648.84 | 24.8% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2020 | 75 | 193 | $92,656 | $17,135 | 18.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 25 | 27 | $8,356 | $1,769 | 21.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 23 | 27 | $7,902 | $1,266 | 16.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 24 | 26 | $4,960 | $1,116 | 22.5% |
About Dr. Catherine Ham, MD
Dr. Catherine Ham, MD is a Neurology healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1609073139.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Catherine Ham, MD has received a total of $551,939 in payments from pharmaceutical and medical device companies, with $52,550 received in 2024. These payments were reported across 683 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($411,140).
As a Medicare-enrolled provider, Ham has provided services to 618 Medicare beneficiaries, totaling 22,582 services with total Medicare billing of $195,373. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Richmond, VA
- Active Since 06/28/2007
- Last Updated 02/06/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1609073139
Products in Payments
- Aimovig (Biological) $187,547
- VYEPTI (Biological) $81,888
- UBRELVY (Drug) $74,990
- QULIPTA (Drug) $69,030
- NURTEC ODT (Drug) $67,311
- AJOVY (Drug) $37,427
- BOTOX (Biological) $13,324
- AJOVY (Biological) $12,300
- ULTOMIRIS (Biological) $200.00
- EMGALITY (Drug) $199.86
- GENERAL - PAIN MANAGEMENT (Device) $118.38
- LEMTRADA (Drug) $110.94
- Trudhesa (Drug) $89.67
- ONZETRA Xsail (Drug) $78.17
- BOTOX CHRONIC MIGRAINE (Drug) $59.72
- BOTOX-NEUROLOGY (Drug) $55.02
- BOTOX THERAPEUTIC (Biological) $52.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Richmond
Dr. Daniel Hardy, M.d, M.D
Neurology — Payments: $360,216
Neurology $360,216
Myla Goldman, Md, MD
Neurology — Payments: $211,301
Neurology $211,301
Dr. Alan Schulman, M.d, M.D
Neurology — Payments: $171,196
Neurology $171,196
Dr. Warren Felton, M.d, M.D
Neurology — Payments: $108,879
Neurology $108,879
Dr. Matthew Boyce, M.d, M.D
Neurology — Payments: $103,206
Neurology $103,206
John Wittman, M.d, M.D
Neurology — Payments: $96,999
Neurology $96,999